Compare JXG & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JXG | PFSA |
|---|---|---|
| Founded | N/A | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 11.1M |
| IPO Year | N/A | N/A |
| Metric | JXG | PFSA |
|---|---|---|
| Price | $7.91 | $0.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 203.8K | ★ 10.7M |
| Earning Date | 05-14-2026 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.26 | N/A |
| Revenue | ★ $46,835,624.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.54 | ★ N/A |
| Revenue Growth | 21.68 | ★ 122.22 |
| 52 Week Low | $3.01 | $0.07 |
| 52 Week High | $73.80 | $12.76 |
| Indicator | JXG | PFSA |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | N/A |
| Support Level | $8.44 | N/A |
| Resistance Level | $10.00 | N/A |
| Average True Range (ATR) | 1.62 | 0.00 |
| MACD | -0.15 | 0.00 |
| Stochastic Oscillator | 51.03 | 0.00 |
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.
Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.